Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US FDA 2020 Budget Request Is Parting Gift From Commissioner Gottlieb

Executive Summary

The Trump Administration’s request to increase FDA funding by 12% is a reminder of the behind-the-scenes benefits brought to FDA by the outgoing commissioner. The proposed increase for FDA stands in stark contrast to what is otherwise an austerity budget for HHS agencies.

Related Content

US FDA Reorg: Defining The “Central” Purpose Of A Commissioner
Gottlieb Touts US FDA's Organizational Structure For Advancing Policies During His Tenure
Opioids, Old Initiatives Dominate FY 2020 US FDA Funding Increase
New Acting US FDA Commissioner Shares Agency's Clinical Trial Reform Message
Trump FY 2020 Budget Renews Push To Reform 180-Day Exclusivity





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts